Developing solutions to better identify, treat and engage people with sleep apnea
What is the sleep apnea program?
In 2018, Verily and ResMed, a global digital health and sleep apnea leader, launched a joint venture to develop new solutions that enable healthcare providers to more efficiently identify, diagnose, treat, and manage individuals with sleep apnea and other breathing related sleep disorders. This effort combines ResMed’s expertise in sleep apnea and our advanced health data analytics with the goal of increasing patient adherence and optimizing health.
How are you making it happen?
In the first phase of our collaboration, we’re collecting evidence on strategies that support adherence to obstructive sleep apnea (OSA) therapy through dedicated clinical research. Most recently, we launched a study to evaluate whether a virtual OSA management platform can improve sleep health. We partner with certified sleep physicians, who are paired with participants, to provide a streamlined care pathway. This study has the potential to provide meaningful insights to inform new approaches to OSA diagnosis and care.